XML 26 R6.htm IDEA: XBRL DOCUMENT v3.20.2
CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Common Shares
Cumulative Common Distributions
Additional Paid in Capital
Cumulative Net Income Available for Common Shareholders
Cumulative Other Comprehensive Income (Loss)
Beginning balance (in shares) at Dec. 31, 2018   164,441,709        
Beginning balance at Dec. 31, 2018 $ 2,597,431 $ 1,644 $ (5,181,323) $ 4,545,481 $ 3,231,895 $ (266)
Increase (Decrease) in Shareholders' Equity            
Net income (loss) 225,787       225,787  
Equity interest in investee’s unrealized gains (losses) 66         66
Common share grants 436     436    
Distributions (87,154)   (87,154)      
Ending balance (in shares) at Mar. 31, 2019   164,441,709        
Ending balance at Mar. 31, 2019 2,736,566 $ 1,644 (5,268,477) 4,545,917 3,457,682 (200)
Beginning balance (in shares) at Dec. 31, 2018   164,441,709        
Beginning balance at Dec. 31, 2018 2,597,431 $ 1,644 (5,181,323) 4,545,481 3,231,895 (266)
Increase (Decrease) in Shareholders' Equity            
Net income (loss) 274,643          
Equity interest in investee’s unrealized gains (losses) 91          
Ending balance (in shares) at Sep. 30, 2019   164,565,303        
Ending balance at Sep. 30, 2019 2,608,986 $ 1,646 (5,446,078) 4,547,055 3,506,538 (175)
Beginning balance (in shares) at Mar. 31, 2019   164,441,709        
Beginning balance at Mar. 31, 2019 2,736,566 $ 1,644 (5,268,477) 4,545,917 3,457,682 (200)
Increase (Decrease) in Shareholders' Equity            
Net income (loss) 8,782       8,782  
Equity interest in investee’s unrealized gains (losses) 71         71
Common share grants (in shares)   15,000        
Common share grants 869 $ 1   868    
Common share repurchases (in shares)   (2,172)        
Common share repurchases (48)     (48)    
Distributions (88,798)   (88,798)      
Ending balance (in shares) at Jun. 30, 2019   164,454,537        
Ending balance at Jun. 30, 2019 2,657,442 $ 1,645 (5,357,275) 4,546,737 3,466,464 (129)
Increase (Decrease) in Shareholders' Equity            
Net income (loss) 40,074       40,074  
Equity interest in investee’s unrealized gains (losses) (46)         (46)
Common share grants (in shares)   140,100        
Common share grants 1,068 $ 1   1,067    
Common share repurchases (in shares)   (29,334)        
Common share repurchases (749)     (749)    
Distributions (88,803)   (88,803)      
Ending balance (in shares) at Sep. 30, 2019   164,565,303        
Ending balance at Sep. 30, 2019 2,608,986 $ 1,646 (5,446,078) 4,547,055 3,506,538 (175)
Beginning balance (in shares) at Dec. 31, 2019   164,563,034        
Beginning balance at Dec. 31, 2019 2,505,878 $ 1,646 (5,534,942) 4,547,529 3,491,645 0
Increase (Decrease) in Shareholders' Equity            
Net income (loss) (33,650)       (33,650)  
Common share grants (in shares)   6,000        
Common share grants $ 590     590    
Common share repurchases (in shares) (2,637) (2,637)        
Common share repurchases $ (43)     (43)    
Distributions (90,509)   (90,509)      
Ending balance (in shares) at Mar. 31, 2020   164,566,397        
Ending balance at Mar. 31, 2020 2,382,266 $ 1,646 (5,625,451) 4,548,076 3,457,995 0
Beginning balance (in shares) at Dec. 31, 2019   164,563,034        
Beginning balance at Dec. 31, 2019 2,505,878 $ 1,646 (5,534,942) 4,547,529 3,491,645 0
Increase (Decrease) in Shareholders' Equity            
Net income (loss) (173,641)          
Equity interest in investee’s unrealized gains (losses) 63          
Ending balance (in shares) at Sep. 30, 2020   164,823,833        
Ending balance at Sep. 30, 2020 2,242,084 $ 1,648 (5,627,097) 4,549,466 3,318,004 63
Beginning balance (in shares) at Mar. 31, 2020   164,566,397        
Beginning balance at Mar. 31, 2020 2,382,266 $ 1,646 (5,625,451) 4,548,076 3,457,995 0
Increase (Decrease) in Shareholders' Equity            
Net income (loss) (37,349)       (37,349)  
Common share grants (in shares)   35,000        
Common share grants $ 831     831    
Common share repurchases (in shares) (3,808)          
Common share repurchases and forfeitures (in shares)   (3,808)        
Common share repurchases and forfeitures $ (27)     (27)    
Ending balance (in shares) at Jun. 30, 2020   164,597,589        
Ending balance at Jun. 30, 2020 2,345,721 $ 1,646 (5,625,451) 4,548,880 3,420,646 0
Increase (Decrease) in Shareholders' Equity            
Net income (loss) (102,642)       (102,642)  
Equity interest in investee’s unrealized gains (losses) 63         63
Common share grants (in shares)   264,400        
Common share grants 871 $ 3   868    
Common share repurchases and forfeitures (in shares)   (38,156)        
Common share repurchases and forfeitures (283) $ (1)   (282)    
Distributions (1,646)   (1,646)      
Ending balance (in shares) at Sep. 30, 2020   164,823,833        
Ending balance at Sep. 30, 2020 $ 2,242,084 $ 1,648 $ (5,627,097) $ 4,549,466 $ 3,318,004 $ 63